Voter Information Services (logo)Helping Voters get beyond the sound bites since 1995
106: S.784 - Medicare Cancer Clinical Trial Coverage Act of 1999.
Back
Legislation Titles

The National Breast Cancer Coalition
Medicare Cancer Clinical Trials Coverage Act (S. 784).
NBCC has made passage of the Breast and Cervical Cancer Treatment Act (H.R. 1070/S. 662) one of our highest priorities for the remainder of the 106th Congress. This legislation would close a critical gap in an existing federal policy (established by Congress in 1990) that screens low-income women for breast and cervical cancer, and then leaves them to scramble for treatment that is becoming increasingly difficult to secure.

The Centers for Disease Control and Prevention’s (CDC) Breast and Cervical Cancer Early Detection Program (BCCEDP) currently relies on an ad-hoc system of charity care to treat women diagnosed through the program. The current strategy for finding these women treatment is fragile and deteriorating. Resources are being diverted away from the screening program which is currently only able to screen about 15% nationally of the women who are eligible.

Patients from all over the country who have been screened through this program, BCCEDP coordinators and physicians providing charity care to the women the program has diagnosed have testified about the vital need for the treatment component that passage of the Breast and Cervical Cancer Treatment Act would provide.


VIS/Thomas
Medicare Cancer Clinical Trial Coverage Act of 1999.

 
You can obtain the list of the U.S. Congress members who cosponsored this and other legislations (bills) through our Congress Position Report.
 
Use our Congressional Report Cards to find out what the advocacy groups listed in the Source column above have to say about this legislation. 
Contact UsPrivacy StatementTop
Copyright © 1995-2013 Voter Information Services. All rights reserved